Injecting drug users will be offered a breakthrough treatment for hepatitis C as part of a Melbourne study to assess whether treating them can reduce transmission of the virus in the community.
17 December 2014 | Sydney Morning Herald
Lax oversight of blood banks means about a fifth of patients in Pakistan who get regular transfusions have been infected with hepatitis, a top government health official said on Friday. Some also get HIV.
09 December 2014 | HepatitisCNewDrugs
A new vaccine developed by researchers at the University of Oxford has generated a strong immune response against the Hepatitis C virus in human volunteers. The vaccine is the first Hepatitis C inoculation to reach this stage of clinical trials, and the results have been promising. The 15 healthy human volunteers who took part in the phase 1 safety trial all responded positively.The study found that after the second, booster inoculation, all 15 volunteers had large, broad and sustained T cells responses.
26 November 2014 | Cherwell
The aim of this document is to reinforce the need for urgent leadership from the Department of Health, PHE and NHS England and concerted action from Local Authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (CCGs) and service providers to improve hepatitis C testing and treatment services in London for people with a history of using drugs – the group most affected by chronic hepatitis C – in order to find and treat significantly more people affected by the disease.
17 November 2014 | London Joint Working Group on Substance Use and Hepatitis C
Dr Vivian Hope of Public Health England said: "With around half of those people living with hepatitis C still unaware of their infection, we need to do more to increase diagnosis rates. Ultimately, this will help reduce the current high level of infection we’re still seeing among people who inject drugs."
05 November 2014 | Public Health England press release
Young drug injectors who undergo opioid agonist maintenance therapy using buprenorphine or methadone have a lower likelihood of becoming infected with hepatitis C virus (HCV) than those who continue injecting or use other types of substance use treatment, according to a study published in the October 27 edition of JAMA Internal Medicine.
29 October 2014 | HIVandhepatitis.com
Hepatitis C virus (HCV) is known to be sexually transmitted among HIV positive men who have sex with men, but HIV negative men may be at risk as well, according to recent reports. Other recent studies have looked at awareness of HCV sexual transmission and screening practices, suggesting that improvement is needed in both areas.
16 October 2014 | HIVandHepatitis.com
Country-wide campaigns to combat schistosomiasis in the 1960’s and 70’s may not be the major cause of the Egypt’s hepatitis C epidemic. Widespread breaches of hygiene in medical care are largely responsible.
15 October 2014 | Nature Middle East
Given the reports about the high-risk practices taking place in London (and likely other cities in high-income countries), it is likely that cases of sexually transmitted HCV are also occurring in some HIV-negative MSM. To investigate this possibility, researchers in London reviewed health-related information collected from HIV-negative patients who sought care at selected clinics in that city.
01 October 2014 | CATIE
The Kirby Institute’s Annual Surveillance Report suggests a number of STIs are continuing to increase, with syphilis and gonorrhoea leading the charge. Hepatitis C infections are also a growing health issue with more people now dying from viral hepatitis infection than from HIV when it was in its peak in the 80s and 90s.
22 September 2014 | Gay News Network